Antiangiogenic agents in cancer therapy:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Totowa, NJ
Humana Press
1999
|
| Schriftenreihe: | Cancer drug discovery and development
3 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XI, 450 S. Ill., graph. Darst. |
| ISBN: | 0896036413 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012309223 | ||
| 003 | DE-604 | ||
| 005 | 20080609 | ||
| 007 | t | ||
| 008 | 981209s1999 ad|| |||| 00||| eng d | ||
| 020 | |a 0896036413 |9 0-89603-641-3 | ||
| 035 | |a (OCoLC)40075837 | ||
| 035 | |a (DE-599)BVBBV012309223 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 | ||
| 050 | 0 | |a RC271.N46 | |
| 082 | 0 | |a 616.99/4061 |2 21 | |
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Antiangiogenic agents in cancer therapy |c ed. by Beverly A. Teicher |
| 264 | 1 | |a Totowa, NJ |b Humana Press |c 1999 | |
| 300 | |a XI, 450 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer drug discovery and development |v 3 | |
| 650 | 7 | |a Inhibitie |2 gtt | |
| 650 | 7 | |a Kanker |2 gtt | |
| 650 | 7 | |a Vascularisatie |2 gtt | |
| 650 | 4 | |a Antineoplastic Agents |x therapeutic use | |
| 650 | 4 | |a Cancer |x Chemotherapy | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 650 | 4 | |a Neovascularization inhibitors | |
| 650 | 4 | |a Neovascularization, Pathologic |x drug therapy | |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Inhibition |0 (DE-588)4273127-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Vaskularisation |0 (DE-588)4187429-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Angiogenese |0 (DE-588)4142449-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Angiogenese |0 (DE-588)4142449-9 |D s |
| 689 | 0 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Vaskularisation |0 (DE-588)4187429-8 |D s |
| 689 | 1 | 2 | |a Inhibition |0 (DE-588)4273127-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Teicher, Beverly A. |e Sonstige |4 oth | |
| 830 | 0 | |a Cancer drug discovery and development |v 3 |w (DE-604)BV011340435 |9 3 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008344476&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008344476 | ||
Datensatz im Suchindex
| _version_ | 1804126933113372672 |
|---|---|
| adam_text | CONTENTS Preface v
Contributors ix
Part I. Antiangiogenic Factors and Tumor Vasculature 1
1 Angiogenesis and Blood Flow in the Solid Tumors 3
Zishatt Haroon, Kevin G. Peters, Charles S. Greenberg,
and Mark W. Dewhirst
2 Oxygenation of Solid Tumors in Animals and Patients 23
Eric Lartigau and Marcelle Guichard
3 Role of Inflammatory Mediators in Angiogenesis 37
Federico Bussolino and Alberto Mantovani
4 Intra and Extracellular pH in Solid Tumors 51
Chang W. Song, HeonJoo Park, and Brian D. Ross
5 Contribution of the Extracellular Matrix and Macrophages
in Angiogenesis 65
Peter J. Polverini
6 Regulation of Angiogenesis by the Organ Microenvironment 77
Diane R. Bielenberg and Isaiah J. Fidler
7 Fibroblast Growth Factors in Tumor Progression
and Angiogenesis 93
Israel Vlodavsky and Gerhard Christofori
8 Role of Vascular Endothelial Growth Factor in Regulation
of Angiogenesis 119
Napoleone Ferrara
9 Regulatory Aspects of Neovascularization: Regulation
of Wound A ngiogenesis by Metabolic A Iterations 143
M. Zamirul Hussain, Q. Perveen Ghani, John J. Feng,
and Thomas K. Hunt
Part II. Antiangiogenic Agents 151
10 Squalamine: A New Angiostatic Steroid 153
Jon I. Williams
11 Cartilage as a Source of Natural Inhibitors of Angiogenesis 175
Vincent Castronovo, Violetta Dimitriadou, Pierre Savard,
Marc Riviere, and Eric Dupont
12 Thrombospondin as an Inhibitor of Angiogenesis 185
David W. Dawson and Noel P. Bouk
13 Matrix Metalloproteinase Inhibitors 205
Peter D. Brown and Mark Whittaker
viii Contents
14 Angiostatin and Other Plasminogen Fragments 225
B. Kim Lee Sim
15 Dietary and Nutritional Modulation of Tumor Angiogenesis 237
Puma Mukherjee, Jin Rong Zhou, Alexander V. Sotnikov,
and Steven K. Clinton
16 Thalidomide and Analogs 263
Taturo Udagawa, HenkM. W. Verheul, andRobert J. D Amato
Part III. In Vivo Studies and Clinical Trials 275
17 Potentiation of Cytotoxic Cancer Therapies by Antiangiogenic
Agents 277
Beverly A. Teicher
18 Prognostic Significance of Tumor Vascularity 317
Gianpietro Gasparini and Adrian L. Harris
19 Endpoints for Determination of Efficacy of Antiangiogenic
Agents in Clinical Trials 341
William J. Gradishar
20 Retinoids and Interferons as Antiangiogenic Cancer Drugs 355
John L. Clifford, Jospeh M. Miano, and Scott M. Lippman
21 Pentosan Polysulfate: A Polysaccharide That Inhibits
Angiogenesis by Binding Growth Factors 371
William D. Figg, James M. Pluda, and Oliver Sartor
22 TNP 470 385
Deborah M. Milkowski and Rachelle A. Weiss
23 Batmastat and Marmastat in Cancer: Summary of Early
Clinical Data 399
Henrik S. Rasmussen
24 Thalidomide: A Prodrug That Inhibits Angiogenesis 407
William D. Figg, Eddie Reed, Shawn Green,
and James M. Pluda
25 Ribozyme Targeting of Angiogenic Molecules 423
Anton Wellstein, Anke M. Schulte, Claudius Malerczyk,
Anne T. Tuveson, Achim Aigner, Frank Czubayko,
and Anna T. Rigel
Index 443
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012309223 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.N46 |
| callnumber-search | RC271.N46 |
| callnumber-sort | RC 3271 N46 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 7000 |
| ctrlnum | (OCoLC)40075837 (DE-599)BVBBV012309223 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02308nam a2200589 cb4500</leader><controlfield tag="001">BV012309223</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080609 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">981209s1999 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0896036413</subfield><subfield code="9">0-89603-641-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)40075837</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012309223</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.N46</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antiangiogenic agents in cancer therapy</subfield><subfield code="c">ed. by Beverly A. Teicher</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 450 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer drug discovery and development</subfield><subfield code="v">3</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inhibitie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vascularisatie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neovascularization inhibitors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neovascularization, Pathologic</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Inhibition</subfield><subfield code="0">(DE-588)4273127-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Vaskularisation</subfield><subfield code="0">(DE-588)4187429-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Angiogenese</subfield><subfield code="0">(DE-588)4142449-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Angiogenese</subfield><subfield code="0">(DE-588)4142449-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Vaskularisation</subfield><subfield code="0">(DE-588)4187429-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Inhibition</subfield><subfield code="0">(DE-588)4273127-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teicher, Beverly A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer drug discovery and development</subfield><subfield code="v">3</subfield><subfield code="w">(DE-604)BV011340435</subfield><subfield code="9">3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008344476&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008344476</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV012309223 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:25:19Z |
| institution | BVB |
| isbn | 0896036413 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008344476 |
| oclc_num | 40075837 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 |
| owner_facet | DE-355 DE-BY-UBR DE-12 |
| physical | XI, 450 S. Ill., graph. Darst. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Humana Press |
| record_format | marc |
| series | Cancer drug discovery and development |
| series2 | Cancer drug discovery and development |
| spelling | Antiangiogenic agents in cancer therapy ed. by Beverly A. Teicher Totowa, NJ Humana Press 1999 XI, 450 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer drug discovery and development 3 Inhibitie gtt Kanker gtt Vascularisatie gtt Antineoplastic Agents therapeutic use Cancer Chemotherapy Neoplasms drug therapy Neovascularization inhibitors Neovascularization, Pathologic drug therapy Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Inhibition (DE-588)4273127-6 gnd rswk-swf Vaskularisation (DE-588)4187429-8 gnd rswk-swf Angiogenese (DE-588)4142449-9 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Angiogenese (DE-588)4142449-9 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Vaskularisation (DE-588)4187429-8 s Inhibition (DE-588)4273127-6 s Teicher, Beverly A. Sonstige oth Cancer drug discovery and development 3 (DE-604)BV011340435 3 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008344476&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Antiangiogenic agents in cancer therapy Cancer drug discovery and development Inhibitie gtt Kanker gtt Vascularisatie gtt Antineoplastic Agents therapeutic use Cancer Chemotherapy Neoplasms drug therapy Neovascularization inhibitors Neovascularization, Pathologic drug therapy Krebs Medizin (DE-588)4073781-0 gnd Inhibition (DE-588)4273127-6 gnd Vaskularisation (DE-588)4187429-8 gnd Angiogenese (DE-588)4142449-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4073781-0 (DE-588)4273127-6 (DE-588)4187429-8 (DE-588)4142449-9 (DE-588)4076066-2 (DE-588)4143413-4 |
| title | Antiangiogenic agents in cancer therapy |
| title_auth | Antiangiogenic agents in cancer therapy |
| title_exact_search | Antiangiogenic agents in cancer therapy |
| title_full | Antiangiogenic agents in cancer therapy ed. by Beverly A. Teicher |
| title_fullStr | Antiangiogenic agents in cancer therapy ed. by Beverly A. Teicher |
| title_full_unstemmed | Antiangiogenic agents in cancer therapy ed. by Beverly A. Teicher |
| title_short | Antiangiogenic agents in cancer therapy |
| title_sort | antiangiogenic agents in cancer therapy |
| topic | Inhibitie gtt Kanker gtt Vascularisatie gtt Antineoplastic Agents therapeutic use Cancer Chemotherapy Neoplasms drug therapy Neovascularization inhibitors Neovascularization, Pathologic drug therapy Krebs Medizin (DE-588)4073781-0 gnd Inhibition (DE-588)4273127-6 gnd Vaskularisation (DE-588)4187429-8 gnd Angiogenese (DE-588)4142449-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Inhibitie Kanker Vascularisatie Antineoplastic Agents therapeutic use Cancer Chemotherapy Neoplasms drug therapy Neovascularization inhibitors Neovascularization, Pathologic drug therapy Krebs Medizin Inhibition Vaskularisation Angiogenese Pharmakotherapie Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008344476&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV011340435 |
| work_keys_str_mv | AT teicherbeverlya antiangiogenicagentsincancertherapy |